Back to Search
ELLEN COHEN, M.D.
M.D.
Psychiatry Physician
NPI: 1770672800Individual
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
59679(MA)
Research & Publications (20)
Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy.
PMID 19340870·Head Neck·2009
8-other
Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study.
PMID 19201650·Lancet Oncol·2009
3-trial
Factors associated with clinical benefit from epidermal growth factor receptor inhibitors in recurrent and metastatic squamous cell carcinoma of the head and neck.
PMID 19586795·Oral Oncol·2009
3-trial
The case against the use of steroids in the treatment of bacterial keratitis.
PMID 19139349·Arch Ophthalmol·2009
7-preclinical
A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle.
PMID 19117988·Cancer Res·2009
7-preclinical
Determinants of spontaneous activity in networks of cultured hippocampus.
PMID 18602907·Brain Res·2008
7-preclinical
Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study.
PMID 18541897·J Clin Oncol·2008
3-trial
Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer.
PMID 17293229·Int J Radiat Oncol Biol Phys·2007
3-trial
A disturbance in the force--mitochondrial mutations in squamous cell carcinoma of the head and neck.
PMID 17671110·Clin Cancer Res·2007
8-other
Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.
PMID 16778206·Cancer Res·2006
8-other
Role of epidermal growth factor receptor pathway-targeted therapy in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
PMID 16763280·J Clin Oncol·2006
6-review
Analytic approach to the evolutionary effects of genetic exchange.
PMID 16486222·Phys Rev E Stat Nonlin Soft Matter Phys·2006
8-other
High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial.
PMID 16849759·J Clin Oncol·2006
3-trial
Front propagation up a reaction rate gradient.
PMID 16486029·Phys Rev E Stat Nonlin Soft Matter Phys·2005
8-other
Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
PMID 16322304·Clin Cancer Res·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 30 OAK ST
LEXINGTON, MA 02421 - Phone
- (617) 872-9491
Quick Facts
- NPI
- 1770672800
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile